$4.24 -0.08 (-1.85%)
2/10/2012 4:00 PM

Sangamo Biosciences, Inc. (NASDAQ:SGMO)

CAPS Rating: 3 out of 5

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.

Featured Broker Partners


Advertisement